Immunosuppressive and anti-inflammatory properties of engineered nanomaterials

被引:72
作者
Ilinskaya, A. N. [1 ]
Dobrovolskaia, M. A. [1 ]
机构
[1] Leidos Biomed Res Inc, Nanotechnol Characterizat Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
nanoparticles; immune system; immunosuppression; inflammation; anti-inflammatory properties; immune inhibition; DENDRITIC CELLS; LIPID NANOPARTICLES; CONCISE GUIDE; IN-VIVO; LIPOSOMAL GLUCOCORTICOSTEROIDS; INTRAARTICULAR DELIVERY; EXPERIMENTAL ARTHRITIS; PLGA NANOPARTICLES; GOLD NANOPARTICLES; ENHANCED EFFICACY;
D O I
10.1111/bph.12722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoparticle interactions with various components of the immune system are determined by their physicochemical properties such as size, charge, hydrophobicity and shape. Nanoparticles can be engineered to either specifically target the immune system or to avoid immune recognition. Nevertheless, identifying their unintended impacts on the immune system and understanding the mechanisms of such accidental effects are essential for establishing a nanoparticle's safety profile. While immunostimulatory properties have been reviewed before, little attention in the literature has been given to immunosuppressive and anti-inflammatory properties. The purpose of this review is to fill this gap. We will discuss intended immunosuppression achieved by either nanoparticle engineering, or the use of nanoparticles to carry immunosuppressive or anti-inflammatory drugs. We will also review unintended immunosuppressive properties of nanoparticles per se and consider how such properties could be either beneficial or adverse.
引用
收藏
页码:3988 / 4000
页数:13
相关论文
共 135 条
  • [1] Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
    Agnihotri, Sagar M.
    Vavia, Pradeep R.
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2009, 5 (01) : 90 - 95
  • [2] THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: CATALYTIC RECEPTORS
    Alexander, Stephen P. H.
    Benson, Helen E.
    Faccenda, Elena
    Pawson, Adam J.
    Sharman, Joanna L.
    Spedding, Michael
    Peters, John A.
    Harmar, Anthony J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) : 1676 - 1705
  • [3] THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
    Alexander, Stephen P. H.
    Benson, Helen E.
    Faccenda, Elena
    Pawson, Adam J.
    Sharman, Joanna L.
    Spedding, Michael
    Peters, John A.
    Harmar, Anthony J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) : 1797 - 1867
  • [4] THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
    Alexander, Stephen P. H.
    Benson, Helen E.
    Faccenda, Elena
    Pawson, Adam J.
    Sharman, Joanna L.
    Spedding, Michael
    Peters, John A.
    Harmar, Anthony J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) : 1459 - 1581
  • [5] Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation
    Alving, CR
    Swartz, GM
    Wassef, NM
    Ribas, JL
    Herderick, EE
    Virmani, R
    Kolodgie, FD
    Matyas, GR
    Cornhill, JF
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (01): : 40 - 49
  • [6] Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis
    Anderson, Rebecca
    Franch, Angels
    Castell, Margarida
    Perez-Cano, Francisco J.
    Braeuer, Rolf
    Pohlers, Dirk
    Gajda, Mieczyslaw
    Siskos, Alexandros P.
    Katsila, Theodora
    Tamvakopoulos, Constantin
    Rauchhaus, Una
    Panzner, Steffen
    Kinne, Raimund W.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
  • [7] Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production
    Andersson-Willman, Britta
    Gehrmann, Ulf
    Cansu, Zekiye
    Buerki-Thurnherr, Tina
    Krug, Harald F.
    Gabrielsson, Susanne
    Scheynius, Annika
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 264 (01) : 94 - 103
  • [8] Polylactide-cyclosporin A nanoparticles for targeted immunosuppression
    Azzi, Jamil
    Tang, Li
    Moore, Robert
    Tong, Rong
    El Haddad, Najib
    Akiyoshi, Takurin
    Mfarrej, Bechara
    Yang, Sunmi
    Jurewicz, Mollie
    Ichimura, Takaharu
    Lindeman, Neal
    Cheng, Jianjun
    Abdi, Reza
    [J]. FASEB JOURNAL, 2010, 24 (10) : 3927 - 3938
  • [9] Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses
    Barata, Teresa S.
    Teo, Ian
    Brocchini, Steve
    Zloh, Mire
    Shaunak, Sunil
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (06)
  • [10] Poly (lactide-co-glycolide)-Polymethacrylate Nanoparticles for Intramuscular Delivery of Plasmid Encoding Interleukin-10 to Prevent Autoimmune Diabetes in Mice
    Basarkar, Ashwin
    Singh, Jagdish
    [J]. PHARMACEUTICAL RESEARCH, 2009, 26 (01) : 72 - 81